The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N2,N3-bis(3-methoxyphenyl)-6-nitroquinoxaline-2,3-diamine ID: ALA4475754
PubChem CID: 130230727
Max Phase: Preclinical
Molecular Formula: C22H19N5O4
Molecular Weight: 417.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(Nc2nc3ccc([N+](=O)[O-])cc3nc2Nc2cccc(OC)c2)c1
Standard InChI: InChI=1S/C22H19N5O4/c1-30-17-7-3-5-14(11-17)23-21-22(24-15-6-4-8-18(12-15)31-2)26-20-13-16(27(28)29)9-10-19(20)25-21/h3-13H,1-2H3,(H,23,25)(H,24,26)
Standard InChI Key: YFBZHNOVGLRCPR-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
33.1171 -20.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9744 -20.9016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5447 -19.2411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4034 -19.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1153 -19.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5423 -20.8981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4022 -20.4876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9777 -19.2479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2623 -19.6587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8306 -19.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8294 -20.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2610 -20.4871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9797 -18.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6897 -18.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6920 -17.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9848 -16.8017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2737 -17.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2749 -18.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6956 -19.2518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9721 -21.7188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2625 -22.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2599 -22.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9669 -23.3514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6782 -22.9404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6773 -22.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9880 -19.6606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6954 -18.4346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.4009 -16.8062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.3862 -23.3485 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1074 -17.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0936 -22.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 8 1 0
6 12 2 0
12 9 1 0
10 11 1 0
12 2 1 0
10 5 2 0
7 1 1 0
5 4 1 0
1 11 2 0
11 6 1 0
9 3 2 0
4 7 2 0
10 3 1 0
8 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
4 19 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
19 26 2 0
19 27 1 0
15 28 1 0
24 29 1 0
28 30 1 0
29 31 1 0
M CHG 2 19 1 27 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 417.43Molecular Weight (Monoisotopic): 417.1437AlogP: 5.04#Rotatable Bonds: 7Polar Surface Area: 111.44Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.14CX Basic pKa: 0.67CX LogP: 4.99CX LogD: 4.99Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.32Np Likeness Score: -1.20
References 1. (2017) Aryl amine substituted quinoxaline used as anticancer drugs,